2004
DOI: 10.1016/j.ejca.2003.11.021
|View full text |Cite
|
Sign up to set email alerts
|

Orthotopic models of cancer for preclinical drug evaluation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
216
0
8

Year Published

2006
2006
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 292 publications
(226 citation statements)
references
References 27 publications
2
216
0
8
Order By: Relevance
“…All animals injected with LS174T tumor cells subcutaneously developed tumors. Tumors became palpable at Ϸ9 days after injection and were measured up to Ϸ17 days after injection, where the tumor reached Ϸ1000 mm 3 . No animal in either cohort dropped below 85% of its starting weight at any timepoint, nor did any increase dramatically with tumor onset.…”
Section: Adverse Effectsmentioning
confidence: 99%
See 4 more Smart Citations
“…All animals injected with LS174T tumor cells subcutaneously developed tumors. Tumors became palpable at Ϸ9 days after injection and were measured up to Ϸ17 days after injection, where the tumor reached Ϸ1000 mm 3 . No animal in either cohort dropped below 85% of its starting weight at any timepoint, nor did any increase dramatically with tumor onset.…”
Section: Adverse Effectsmentioning
confidence: 99%
“…2c,d), which is most likely due to an underestimation of the mean value at this timepoint caused by fewer animal numbers. However, considering the animals individually, the maximum tumor volume reached was 5500 mm 3 and the estimated mean doubling time (Td) was Ϸ2-3 days. In contrast, subcutaneous LS174T xenografts became palpable at 6 -7 days postinoculation, reaching a mean tumor volume of 700 mm 3 17 days after inoculation.…”
Section: Metastatic Progression Assessed By Susceptibility Contrast Mrimentioning
confidence: 99%
See 3 more Smart Citations